| Literature DB >> 23573225 |
Monique Robinson1, Andrew J O Whitehouse, Peter Jacoby, Eugen Mattes, Michael G Sawyer, Jeffrey A Keelan, Martha Hickey.
Abstract
Antenatal testosterone exposure influences fetal neurodevelopment and gender-role behavior in postnatal life and may contribute to differences in developmental psychopathology during childhood. We prospectively measured the associations between umbilical cord blood testosterone levels at birth and childhood behavioral development in both males and females from a large population based sample. The study comprised 430 females and 429 males from the Western Australian Pregnancy Cohort (Raine) Study where umbilical cord blood had been collected. Total testosterone concentrations were determined by mass spectrometry and bioavailable testosterone (BioT) levels were calculated. At two, five, eight and ten years of age, the participants completed the Child Behavior Checklist (CBCL). Linear regression models were used to analyse the relationship between BioT concentrations (in quartiles) and CBCL scores (total, internalizing, externalizing and selected syndrome). Boys had higher mean CBCL T-scores than girls across all ages of follow-up. There was no significant relationship between cord blood BioT quartiles and CBCL total, internalizing and externalizing T-scores at age two or five to ten combined. In the syndrome score analyses, higher BioT quartiles were associated with significantly lower scores for attention problems for boys at age five, eight and ten, and greater withdrawal symptoms in pre-school girls (age five). We did not identify a consistent relationship between antenatal testosterone exposure and total, internalizing or externalizing behavioral difficulties in childhood. Higher umbilical cord BioT levels were associated with lower scores for attention problems in boys up to 10 years and more withdrawn behavior in 5-year-old girls; however, these findings were not consistent across ages and require further investigation in a larger sample.Entities:
Mesh:
Substances:
Year: 2013 PMID: 23573225 PMCID: PMC3613417 DOI: 10.1371/journal.pone.0059991
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Frequency characteristics of the sample predictor and control variables.
| Girls | Boys | |
| N = 430 | N = 429 | |
| n (%) | n (%) | |
|
| ||
| None | 264 (61.4) | 251 (58.5) |
| < = once a week | 130 (30.2) | 136 (31.7) |
| >once a week | 21 (4.9) | 25 (5.8) |
| missing | 15 (3.5) | 17 (4.0) |
|
| ||
| None | 303 (70.5) | 312 (72.7) |
| < = 10/day | 65 (15.1) | 52 (12.1) |
| >10/day | 47 (10.9) | 48 (11.2) |
| missing | 15 (3.5) | 17 (4.0) |
|
| ||
| No | 228 (53.0) | 244 (56.9) |
| Yes | 178 (41.4) | 171 (39.9) |
| missing | 24 (5.6) | 14 (3.3) |
|
| ||
| > = yr12 | 147 (34.2) | 155 (36.1) |
| <yr 12 | 266 (61.9) | 263 (61.3) |
| missing | 17 (4.0) | 11 (2.6) |
|
| ||
| No | 47 (10.9) | 56 (13.1) |
| Yes | 366 (85.1) | 362 (84.4) |
| missing | 17 (4.0) | 11 (2.6) |
|
| ||
| 1st child | 209 (48.6) | 192 (44.8) |
| 2nd child | 121 (28.1) | 136 (31.7) |
| 3rd+ child | 99 (23.0) | 101 (23.5) |
| missing | 1 (0.2) | 0 |
|
|
| |
|
| 27.6 (5.9) | 27.6 95.9) |
|
| 273 (17) | 274 (16) |
|
|
| |
|
| 0.07, (0.06) | 0.12, (0.09) |
Figure 1Mean CBCL total, internalizing and externalizing T-scores at age 2 and age 5–10 by BioT quartile for females.
Figure 2Mean CBCL total, internalizing and externalizing T-scores at age 2 and age 5–10 by BioT quartile for males.
Linear regression model of prenatal bioavailable testosterone (BioT) levels on CBCL T-scores at age 2 years.
| Total | Internalizing | Externalizing | |||||||
| BioT quadrant comparison | Effect Sizea | 95%CI | p-value | Effect Sizea | 95%CI | p-value | Effect Sizea | 95%CI | p-value |
|
| 0.49 | −3.19, 4.18 | 0.37 | −0.02 | −3.42, 3.38 | 0.66 | 1.06 | −2.53, 4.65 | 0.33 |
|
| 0.41 | −3.22, 4.05 | 0.08 | −3.27, 3.44 | −0.06 | −3.60, 3.48 | |||
|
| 0.97 | −2.66, 4.61 | 1.90 | −1.46, 5.26 | 0.14 | −3.41, 3.68 | |||
|
| −1.23 | −4.74, 2.28 | 0.14 | −0.69 | −3.85, 2.47 | 0.23 | −1.06 | −4.48, 2.36 | 0.33 |
|
| −0.97 | −4.52, 2.58 | −0.33 | −3.52, 2.87 | −1.47 | −4.94, 1.99 | |||
|
| −2.58 | −5.50, 2.28 | −0.42 | −3.91, 3.07 | −2.24 | −6.03, 1.54 | |||
Longitudinal mixed model adjusted for gestational age, alcohol use and smoking during pregnancy, mother’s education, low family income, parity, mother’s age and presence of labour.
aEffect size refers to the difference between the adjusted mean T-score for each quartile and the reference quartile.
Random effects model effect of prenatal bioavailable testosterone (BioT) levels on CBCL T-scores at age 5–10 years.
| Total | Internalizing | Externalizing | |||||||
| BioT quadrant comparison | Effect Sizea | 95%CI | p-value | Effect Sizea | 95%CI | p-value | Effect Sizea | 95%CI | p-value |
|
| 0.45 | −2.66, 3.56 | 0.96 | −0.52 | −3.32, 2.28 | 0.61 | 0.04 | −2.95, 3.02 | 0.92 |
|
| 2.43 | −0.66, 5.52 | 1.27 | −1.51, 4.05 | 2.25 | −0.72, 5.21 | |||
|
| 1.93 | −1.24, 5.11 | 0.33 | −2.53, 3.19 | 1.79 | −1.25, 4.84 | |||
|
| −0.03 | −2.67, 2.62 | 0.63 | −0.54 | −3.18, 2.08 | 0.98 | 1.09 | −1.57, 3.75 | 0.69 |
|
| −2.36 | −5.12, 0.41 | −2.13 | −4.86, 0.61 | −1.02 | −3.80, 1.76 | |||
|
| −2.44 | −5.33, 0.45 | −2.53 | −5.39, 0.33 | −1.31 | −4.21, 1.60 | |||
Longitudinal mixed model adjusted for gestational age, alcohol use and smoking during pregnancy, mother’s education, low family income, parity, mother’s age and presence of labour.
aEffect size refers to the difference between the adjusted mean T-score for each quartile and the reference quartile.
Modeled effect of prenatal bioavailable testosterone (BioT) levels on raw syndrome scores- males.
| Aggression problems | Attention problems | |||||
| BioT quadrant comparison | Effect sizea | 95%CI | p-value | Effect sizea | 95%CI | p-value |
| Age 2 Q2 v Q1 | 0.92 | 0.74, 1.13 | 0.73 | |||
| Q3 v Q1 | 0.91 | 0.74, 1.14 | ||||
| Q4 v Q1 | 0.88 | 0.70, 1.12 | ||||
| Age 5 Q2 v Q1 | 1.04 | 0.83, 1.29 | 0.21 | 1.02 | 0.79, 1.33 | 0.053 |
| Q3 v Q1 | 0.82 | 0.65, 1.03 | 0.73 | 0.55, 0.97 | ||
| Q4 v Q1 | 0.91 | 0.72, 1.16 | 0.82 | 0.61, 1.10 | ||
| Age 8 Q2 v Q1 | 1.00 | 0.78, 1.28 | 0.61 | 1.04 | 0.78, 1.40 | 0.048 |
| Q3 v Q1 | 1.05 | 0.81, 1.35 | 0.69 | 0.51, 0.95 | ||
| Q4 v Q1 | 0.87 | 0.67, 1.14 | 0.81 | 0.59, 1.11 | ||
| Age 10 Q2 v Q1 | 0.99 | 0.74, 1.32 | 0.28 | 0.83 | 0.59, 1.17 | 0.008 |
| Q3 v Q1 | 0.92 | 0.68, 1.24 | 0.58 | 0.40, 0.83 | ||
| Q4 v Q1 | 0.75 | 0.55, 1.03 | 0.61 | 0.42, 0.88 | ||
Cross-sectional negative binomial models adjusted for gestational age, alcohol use and smoking during pregnancy, mother’s education, low family income, parity, mother’s age and presence of labour.
Attention problems not measured at age 2.
aEffect size refers to the ratio of adjusted raw scores between each quartile and the reference quartile.
Modeled effect of prenatal bioavailable testosterone (BioT) levels on raw syndrome scores- females.
| Social problems | Withdrawn behavior | |||||
| BioT quadrant comparison | Effect sizea | 95%CI | p-value | Effect sizea | 95%CI | p-value |
| Age 2 Q2 v Q1 | 1.05 | 0.79, 1.41 | 0.49 | |||
| Q3 v Q1 | 0.95 | 0.71, 1.27 | ||||
| Q4 v Q1 | 1.18 | 0.89, 1.57 | ||||
| Age 5 Q2 v Q1 | 1.14 | 0.83, 1.56 | 0.52 | 1.63 | 1.18, 2.26 | 0.008 |
| Q3 v Q1 | 1.26 | 0.93, 1.70 | 1.59 | 1.15, 2.19 | ||
| Q4 v Q1 | 1.13 | 0.81, 1.56 | 1.58 | 1.13, 2.21 | ||
| Age 8 Q2 v Q1 | 1.18 | 0.82, 1.69 | 0.57 | 1.14 | 0.80, 1.62 | 0.22 |
| Q3 v Q1 | 1.28 | 0.90, 1.82 | 1.24 | 0.88, 1.75 | ||
| Q4 v Q1 | 1.10 | 0.76, 1.61 | 1.11 | 0.77, 1.60 | ||
| Age 10 Q2 v Q1 | 0.90 | 0.58, 1.39 | 0.96 | 1.11 | 0.76, 1.61 | 0.88 |
| Q3 v Q1 | 0.93 | 0.61, 1.42 | 0.95 | 0.66, 1.38 | ||
| Q4 v Q1 | 0.97 | 0.63, 1.51 | 1.07 | 0.73, 1.56 | ||
Cross-sectional negative binomial models adjusted for gestational age, alcohol use and smoking during pregnancy, mother’s education, low family income, parity, mother’s age and presence of labour.
Social problems not measured at age 2.
aEffect size refers to the ratio of adjusted raw scores between each quartile and the reference quartile.